Gil Bashe

As health systems face mounting operational pressures, Israeli innovators must prove not only that their products work, but that they fit seamlessly into clinical and organizational workflows.

At the DHAI Summit, two connected books and one fireside conversation returned AI to the question that matters most: who is health innovation meant to serve?

From scientific discovery and clinical research to manufacturing and market access, the next era of biotech innovation may belong to ecosystems that collaborate rather than compete.

Capital, talent, scientific infrastructure, and global partnerships are helping position Abu Dhabi as an emerging force in the life sciences sector.

As AI matures, a new generation of health-focused innovators is tackling the industry's most persistent sources of friction.

New documentary series showcased at HLTH EU explores women's health through stories, illuminating challenges and emerging opportunities for change.

Health does not suffer from a shortage of ideas. Every day, scientists, engineers, clinicians and entrepreneurs create medicines, devices and

Why the UK is becoming one of the world's most important models for transforming discovery into real-world health impact

The upcoming second edition of AI in Health pairs a pathfinder’s understanding of AI with a practical guide to making it serve patients, caregivers and health professionals.

India is emerging as a center of scientific innovation, commercial growth and global capability. For US and European life sciences companies, the opportunity extends beyond entering a growing market to helping shape the future of health innovation for middle-income nations.